BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3117700)

  • 1. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.
    Bauernfeind A; Bertele RM; Harms K; Hörl G; Jungwirth R; Petermüller C; Przyklenk B; Weisslein-Pfister C
    Infection; 1987; 15(4):270-7. PubMed ID: 3117700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective media for the quantitation of bacteria in cystic fibrosis sputum.
    Wong K; Roberts MC; Owens L; Fife M; Smith AL
    J Med Microbiol; 1984 Apr; 17(2):113-9. PubMed ID: 6423825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.
    Bauernfeind A; Rotter K; Weisslein-Pfister C
    Infection; 1987; 15(4):278-80. PubMed ID: 3117701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk of cross-colonization in cystic fibrosis holiday camps.
    Hoogkamp-Korstanje JA; van der Laag J
    Antonie Van Leeuwenhoek; 1980; 46(1):100-1. PubMed ID: 6772098
    [No Abstract]   [Full Text] [Related]  

  • 6. Postal transport of sputa from cystic fibrosis patients does not decrease the microbiological yield.
    Hoppe JE; Holzwarth I; Stern M
    Zentralbl Bakteriol; 1997 Nov; 286(4):468-71. PubMed ID: 9440195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis.
    Kerr J
    J Infect; 1994 May; 28(3):305-10. PubMed ID: 7522262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):541-50. PubMed ID: 4153350
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.
    Valenza G; Tappe D; Turnwald D; Frosch M; König C; Hebestreit H; Abele-Horn M
    J Cyst Fibros; 2008 Mar; 7(2):123-7. PubMed ID: 17693140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.
    Seale TW; Thirkill H; Tarpay M; Flux M; Rennert OM
    J Clin Microbiol; 1979 Jan; 9(1):72-8. PubMed ID: 107186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
    Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
    J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Interactions in the Cystic Fibrosis Airway.
    Granchelli AM; Adler FR; Keogh RH; Kartsonaki C; Cox DR; Liou TG
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microbiological study of the respiratory tract in children with cystic fibrosis].
    Muñoz C; Juncosa T; Gené A; Fortea J; Séculi JL; Latorre C
    Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):142-4. PubMed ID: 8695681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients.
    Hogardt M; Trebesius K; Geiger AM; Hornef M; Rosenecker J; Heesemann J
    J Clin Microbiol; 2000 Feb; 38(2):818-25. PubMed ID: 10655391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metagenome - Inferred bacterial replication rates in cystic fibrosis airways.
    Pienkowska K; Wiehlmann L; Tümmler B
    J Cyst Fibros; 2019 Sep; 18(5):653-656. PubMed ID: 30685331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
    Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
    J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.
    Hammerschlag MR; Harding L; Macone A; Smith AL; Goldmann DA
    J Clin Microbiol; 1980 Jun; 11(6):552-7. PubMed ID: 6776135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological identification in cystic fibrosis patients with CFTR I1234V mutation.
    Wahab AA; Janahi IA; Marafia MM; El-Shafie S
    J Trop Pediatr; 2004 Aug; 50(4):229-33. PubMed ID: 15357563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.